Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1958 2
1960 1
1962 2
1965 2
1966 2
1969 1
1971 1
1975 1
1976 2
1979 2
1981 1
1982 2
1984 2
1985 1
1987 2
1989 1
1990 2
1991 5
1994 1
1995 2
1996 1
1997 5
1999 5
2000 5
2001 7
2002 7
2003 13
2004 21
2005 16
2006 45
2007 42
2008 24
2009 15
2010 12
2011 8
2012 8
2013 10
2014 8
2015 4
2016 1
2017 5
2018 4
2019 1
2020 4
2021 4
2022 3
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 17699214

295 results

Results by year

Filters applied: . Clear all
Page 1
Double-blind, placebo-controlled study on the effect of the aldosterone receptor antagonist spironolactone in patients who have persistent proteinuria and are on long-term angiotensin-converting enzyme inhibitor therapy, with or without an angiotensin II receptor blocker.
Chrysostomou A, Pedagogos E, MacGregor L, Becker GJ. Chrysostomou A, et al. Clin J Am Soc Nephrol. 2006 Mar;1(2):256-62. doi: 10.2215/CJN.01040905. Epub 2006 Feb 1. Clin J Am Soc Nephrol. 2006. PMID: 17699214 Clinical Trial.
Effect of renin-angiotensin-aldosterone system triple blockade on non-diabetic renal disease: addition of an aldosterone blocker, spironolactone, to combination treatment with an angiotensin-converting enzyme inhibitor and angiotensin II receptor blocker.
Furumatsu Y, Nagasawa Y, Tomida K, Mikami S, Kaneko T, Okada N, Tsubakihara Y, Imai E, Shoji T. Furumatsu Y, et al. Hypertens Res. 2008 Jan;31(1):59-67. doi: 10.1291/hypres.31.59. Hypertens Res. 2008. PMID: 18360019 Clinical Trial.
Addition of spironolactone to dual blockade of renin angiotensin system dramatically reduces severe proteinuria in renal transplant patients: an uncontrolled pilot study at 6 months.
González Monte E, Andrés A, Polanco N, Toribio MJ, Santana R, Gutiérrez Martínez E, González J, Ramírez E, Hernández A, Morales E, Praga M, Morales JM. González Monte E, et al. Transplant Proc. 2010 Oct;42(8):2899-901. doi: 10.1016/j.transproceed.2010.08.024. Transplant Proc. 2010. PMID: 20970564
295 results